ArticleTherapeutic advances in medical oncology2024

Immune checkpoint inhibitors or anti-claudin 18.2 antibodies? A network meta-analysis for the optimized first-line therapy of HER2-negative gastric cancer.

Zhening Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.